Table 5.
The significance of the association of CRP with versus without individual clinical manifestations and pathergy reaction.
| CRP levels (mg/L) in patients with | CRP levels (mg/L) in patients without | |||||
|---|---|---|---|---|---|---|
| Manifestations | No. of patients | Median | (Range) | Median | (Range) | P-values |
| Oral ulcer | 31 | 12.4 | (3–400) | 8.7 | (3–43) | P = .159 |
| Genital ulcer | 23 | 18 | (3–100) | 8.4 | (3–400) | P = .001* |
| Ocular lesion | 18 | 19.25 | (3–400) | 8.5 | (3–68) | P = .001* |
| Vascular lesion | 37 | 20.5 | (3–400) | 8.4 | (3–51) | P = .001* |
| Arthritis/arthralgia | 25 | 8.4 | (3–400) | 12.9 | (3–400) | P = .201 |
| EN/PPE | 31 | 12.9 | (3–400) | 8.9 | (3–400) | P = .043* |
| (+) pathergy | 35 | 14.8 | (3–400) | 8.7 | (3–400) | P = .016* |
P* < .05 by Mann-Whitney U test (statistically significant with versus without clinical manifestations).
Data are presented as median values and their individual ranges within parentheses.